Page 50 Opióides

60. Stiebel WH, Wessel A, Rieger A, et al. Intranasal fentanyl for breakthrough cancer pain or incident
pain (Abstract). Br J Anaesth 1993;70 Supp 1:109.
61. Hanning CD The rectal absorption of opioids. Em: Benedetti C, Chapman CR, Giron G, eds. Ad-
vances in Pain Research and Therapy. Philadelphia, Pa: Lippincott-Raven 1990;14:259-68.
62. McCaffery M, Martin L, Ferrell BR. Analgesic administration via rectum or stoma. ET Nurs 1992;19(4):
114-21.
63. Conno FD, Ripamonti C, Sbanotto A, et al. The pharmacological management of cancer pain. Annals
of Oncology 1993;4:267-76.
64. Maloney CM, Kesner RK, Klein G, et al. The rectal administration of MS Contin: clinical implications
of use in end stage cancer. Am J Hosp Care 1998;6:34-5.
65. Gerber HR. Intrathecal morphine for chronic benign pain. Best Pract Res Clin Anaesthesiol
2003;17(3):429-42.
66. Wang JK, Nauss LA, Thomas JE. Pain relief by intrathecally applied morphine in man. Anesthesiology
1979;50:149-51.
67. Glynn C, Dawson D, Sanders R. A double-blind comparison between epidural morphine and epidural
clonidine in patients with chronic non-cancer pain. Pain 1988;34:123-8.
68. Hassenbusch SJ, Stanton-Hicks M, Covington EC, et al. Long-term intraspinal infusions of opioids in
the treatment of neuropathic pain. J Pain Symptom Manage 1995;10:527-43.
69. Sylvester RK, Lindsay SM, Schauer C. The conversion challenge: from intrathecal to oral morphine.
Am J Hosp Palliat Care 2004;21(2):143-7.
70. Paice JÁ, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective multicenter study.
J Pain Symptom Manage 1996;11:71-80.
71. Hogan Q, Haddox JD, Abram SE, et al. Epidural opiates and local anesthetics for the management of
cancer pain. Pain 1991;46:271-9.
72. Du Pen SL, Williams AR. Management of patients receiving combined epidural morphine and bupiva-
caine for the treatment of cancer pain. J Pain Symptom Manage 1992;7(2):125-7.
73. Du Pen SL, Ramsey D, Chin S. Chronic epidural morphine and preservative-induced injury. Anesthe-
siology 1987;67(6):987-8.
74. Wang BC, Hillman DE, Spielholz NI, et al. Chronic neurological deficits and nesacaine-CE: an
effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg 1984;
63:445-7.
75. Hammack JE, Loprinzi CL. Use of orally administered opioids for cancer-related pain. Mayo Clin Proc
1994;69(4):384-90.
76. Ferraz AA, Cowles VE, Condon RE, et al. Nonopioid analgesics shorten duration of postoperative
ileus. Am Surg 1995;61(12):1079-83.
77. Glare P, Lickiss JN. Unrecognized constipation in patients with advanced cancer: a recipe for thera-
peutic disaster. J Pain Symptom Manage 1992;7(6):369-71.
78. Levy MH. Constipation and diarrhea in cancer patients. Cancer Bull 1991;43(5):412-22.
79. Sykes NP. Oral naloxone in opioid-associated constipation. Lancet 1991;337:1475.
80. Culpepper-Morgan JA, Inturrisi CE, Portenoy RK, et al. Treatment of opioid-induced constipation with
oral naloxone: a pilot study. Clin Pharmacol Ther 1992;52:90-5.
81. Campora E, Merlini L, Pace M, et al. The incidence of narcotic-induced emesis. Journal of Pain and
Symptom Management 1991;6:428-30.
82. Portenoy KR. Cancer pain: patophysiology and syndromes. The Lancet 1992;339:1026-36.
83. Foley KM, Inturrisi CE. Analgesic drug therapy in cancer pain: Principles and practice. Med Clin North
Am 1987;71:207-32.
84. Ferris FD, Kerr IG, Sone M, et al. Transdermal scopolamine use in the control of narcotic-induced
nausea. J Pain Symptom Manage 1991;6(6):389-93.
85. Bruera E, Macmillan K, Hanson J, et al. The cognitive effects of the administration of narcotic anal-
gesics in patients with cancer pain. Pain 1989:39:13-6.
86. Hanks GW, Twycross RG, Lloyd JW. Unexpected complication of successful nerve block. Mor-
phine induced respiratory depression precipitated by removal of severe pain. Anaesthesia 1981;
36(1):37-9.
87. American Pain Society. Principles of analgesic use in the treatment of acute pain and chronic cancer
pain: a concise guide to medical practice. Skokie IL: American Pain Society 1992.
88. Goldfrank L, Weisman RS, Errick JK, et al. A dosing nomogram for continuous infusion of intravenous
naloxone. Ann Emerg Med 1986;15:566-70.
89. Bradberry JC, Raebel MA. Continuous infusion of naloxonc in the treatment of narcotic overdose.
Drug Intelligence and Clinical Pharmacy 1981;15:945-50.
90. Font LA, Rillo ES. “Opiáceos Y Dolor Postoperatorio” em Dolor Postoperatorio. Permanyer Portugal
2000.

47